TABLE 4

Basic characteristics of the 3013 primary ciliary dyskinesia (PCD) patients included in the international PCD cohort (iPCD Cohort) (April 2016)

Patients3013 (100)
Sex
 Male1490 (49)
 Female1523 (51)
Location of country of residence#
 Australia109 (4)
 Northern Europe515 (17)
 Western Europe1146 (39)
 Eastern Europe105 (4)
 Southern Europe341 (11)
 Western Asia278 (9)
 Northern America418 (14)
 Southern America101 (3)
Diagnostic information
 Definite PCD diagnosis1718 (56)
 Probable PCD diagnosis+420 (14)
 Clinical diagnosis only875 (30)
Age years
 0–9517 (17)
 10–191156 (38)
 20–29553 (18)
 30–39316 (10)
 40–49205 (7)
 50–59137 (5)
 ≥60129 (4)
  • Data are presented as n (%). #: based on geographical region definitions of the United Nations Statistic Division (August 2016) (Northern Europe: Denmark, Norway, UK; Western Europe: Belgium, France, Germany, Switzerland, the Netherlands; Eastern Europe: Poland; Southern Europe: Italy, Serbia; Western Asia: Cyprus, Israel, Turkey; Northern America: Canada, USA; Southern America: Argentina); : defined as hallmark PCD electron microscopy findings and/or bi-allelic gene mutation identified based on the European Respiratory Society PCD Diagnostics Task Force guidelines [11]; +: abnormal light or high-frequency video microscopy finding and/or low (≤77 nL·min−1) nasal nitric oxide value.